Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Intraovarian Injection of Platelet-Rich Plasma and Growth Factors on IVF Outcomes in Patients with Low Ovarian Reserve
2024-517726-26-00Phase 3Authorised
- Sponsor
- IVI Alicante
- Start
- Jul 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial in female infertility comparing PRGF Endoret intraovarian injection with Placebo intraovarian injection (2 arms). Primary endpoint: Number of oocytes retrieved. Planned start Jul 2025; status: authorised.
02
Drugs
PRGF-Endoret
03
Conditions
female infertility
Beyond the preview
Go deeper on 2024-517726-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517726-26-00.